To clarify whether the upregulation of FBXW11 contributes to olaparib-mediated killing or enhances olaparib tolerance in ovarian cancer cells, we silenced the expression of FBXW11 in these three cell lines using siRNA (Figs. 1D and E). The gene discussed is FBXW11; the disease is ovarian carcinoma.